24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Learn about Vyondys 53 (golodirsen) dosage, how it's administered, and important considerations for Duchenne muscular dystrophy patients in India. Understand its mechanism, side effects, and when to seek medical advice.

Duchenne muscular dystrophy (DMD) is a rare genetic disorder that causes progressive muscle degeneration and weakness. It primarily affects boys and is characterized by the absence of dystrophin, a protein essential for muscle function. While there is no cure for DMD, advancements in treatment offer hope for managing the condition and improving the quality of life for patients. One such medication is Vyondys 53, also known by its generic name, golodirsen.
Vyondys 53 is a prescription medication specifically approved for the treatment of Duchenne muscular dystrophy in individuals who have a confirmed mutation in the DMD gene. It belongs to a class of drugs called antisense oligonucleotides. These drugs work by targeting the messenger RNA (mRNA) that carries genetic instructions from DNA to the cell's protein-making machinery. In the case of DMD, Vyondys 53 helps to restore the production of a shortened but functional form of dystrophin, which is crucial for muscle integrity.
The genetic defect in DMD leads to a lack of functional dystrophin. Vyondys 53 is designed to skip over a specific exon (a segment of a gene) in the dystrophin gene's mRNA. By skipping this exon, the cell can produce a shorter, but still functional, version of the dystrophin protein. This restored protein can help to stabilize muscle fibers and slow down the progression of muscle degeneration.
It is crucial to understand that the dosage and administration of Vyondys 53 are determined by a healthcare professional based on individual patient factors. The information provided here is for general understanding and should not replace medical advice.
Vyondys 53 is available as a liquid solution. The standard strength of Vyondys 53 is 50 mg/mL of solution.
Vyondys 53 is administered through an intravenous (IV) infusion. This means the medication is slowly introduced into a vein, usually in the arm. The infusion is typically given once per week. A healthcare professional will administer the infusion in a clinical setting, ensuring proper technique and monitoring for any immediate reactions.
The exact dosage of Vyondys 53 is prescribed by your doctor. They will consider several factors, including:
Your doctor will order necessary tests, including genetic testing, to confirm if Vyondys 53 is an appropriate treatment for you or your child. The dose is measured in milligrams (mg) per kilogram (kg) of body weight. For example, a common dosage regimen might be 4 mg/kg administered weekly. However, this is just an example, and your doctor will provide the precise prescription.
Before starting Vyondys 53, a genetic test is essential to confirm that the patient has a specific type of mutation in the DMD gene that can be targeted by this medication. This test ensures that the drug will be effective.
The IV infusion process can take some time. The healthcare provider may numb the skin area where the needle will be inserted to minimize discomfort. It is important to remain still during the infusion. Patients and caregivers should communicate any discomfort or unusual sensations to the medical staff immediately.
Like all medications, Vyondys 53 can have side effects. Common side effects may include reactions at the infusion site, fever, headache, and upper respiratory tract infections. More serious side effects are possible, though less common. Your doctor will monitor you closely for any adverse reactions. If you experience side effects, your doctor may adjust the dosage or recommend other management strategies. It is vital to report any new or worsening symptoms to your healthcare provider promptly.
Regular follow-up appointments and tests will be scheduled to monitor the effectiveness of Vyondys 53 and to check for any side effects. This may include blood tests, physical examinations, and functional assessments to evaluate muscle strength and function.
It is imperative to consult with a qualified healthcare professional for any questions or concerns regarding Vyondys 53 or Duchenne muscular dystrophy. Specifically, you should consult a doctor if:
Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026